Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
09/20/2024 | Press release | Distributed by Public on 09/20/2024 14:49
Please select the service you want to use:
Smartlinks | Siebert Financial Corporation | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Shareholders | Shareholder Meeting | Proxy Statements | Financial Services | Securities Issuers | Investment Companies | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact